# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028463
Filing Date
2022-11-04
Accepted
2022-11-04 16:18:55
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcrx-20220930.htm iXBRL | 10-Q | 1688187
2 | EX-10.1 | exhibit101-biocrystxbcx993.htm | EX-10.1 | 52515
3 | EX-10.2 | exhibit102-biocrystxamendm.htm | EX-10.2 | 46733
4 | EX-10.4 | bcrx-20220930xexhibit104.htm | EX-10.4 | 12465
5 | EX-31.1 | bcrx-20220930xexx311.htm | EX-31.1 | 9576
6 | EX-31.2 | bcrx-20220930xexx312.htm | EX-31.2 | 9550
7 | EX-32.1 | bcrx-20220930xexx321.htm | EX-32.1 | 4725
8 | EX-32.2 | bcrx-20220930xexx322.htm | EX-32.2 | 4655
| Complete submission text file | 0001628280-22-028463.txt |  | 7547783

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcrx-20220930.xsd | EX-101.SCH | 62273
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcrx-20220930_cal.xml | EX-101.CAL | 50195
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcrx-20220930_def.xml | EX-101.DEF | 253001
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcrx-20220930_lab.xml | EX-101.LAB | 658367
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcrx-20220930_pre.xml | EX-101.PRE | 381002
60 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx-20220930_htm.xml | XML | 1224484

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 221362587
SIC: 2836 Biological Products, (No Diagnostic Substances)